Eight-Year Experience Of HDR Brachytherapy Boost For Localized Prostate Cancer: Biopsy And PSA Outcome (Medical News Today) PDF Print

UroToday.com - In 2004, we reported our observations on early toxicity in patients treated with an inversely planned high-dose rate (HDR) brachytherapy boost. In this study, we present our most recent observations on biochemical and pathological controls for patients with localized prostate cancer at intermediate and high risk of recurrence.

read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.